Moreover, although RbvDR are considered by the experts to be the best strategy to manage severe anemia during TVR, in some cases severe anemia is so quick to develop that erythropoietin and blood transfusion are necessary to improve the patients quality of life while continuing PR+TVR treatment. This evidence concerns the gene EPO and anemia (phenotype).